Printer Friendly

Pass the doobie, pops.

It was only a matter of time, given the inevitability of irony in this life. Researchers have found that a synthetic analogue of the active component of marijuana may prevent the cognitive decline in Alzheimer's disease. The same ingredient that at this very moment has stoned college students all over the United States looking high and low for their cell phones may have a clarifying effect on the cognitive function of their grandparents, enabling esteemed elders to live independently and safely. The observation comes from a study in which researchers injected cannabinoid or placebo and either amyloid or control protein into the brains of rats. After 2 months of injections, the researchers attempted to train the rats to find an underwater platform. The rats treated with cannabinoid and amyloid were the only ones able to find the platform. The combination activated immune cells to reduce inflammation and improve cognitive function. In a sad day for some of the Grateful Dead's oldest fans, future research will focus on the cannabinoid receptors not involved in producing the psychotropic effects associated with marijuana use.
COPYRIGHT 2005 International Medical News Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:INDICATIONS
Author:Kubetin, Sally Koch
Publication:Internal Medicine News
Article Type:Brief Article
Geographic Code:1USA
Date:Mar 15, 2005
Previous Article:Listerine neat, with a chaser.
Next Article:Device may reduce liver biopsy rate.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters